Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1

American Journal of Neuroradiology

Volumn 28, Issue 4, 2007, Pages 773-776

  Zamboni, S L ^a   Loenneker, Thomas ^a,b   Boltshauser, E ^a   Martin, E ^a   Il'yasov, K A ^a,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANISOTROPY; ARTICLE; BASAL GANGLION; BRAIN REGION; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; EARLY DIAGNOSIS; EVALUATION; FEMALE; FRONTAL CORTEX; HEMISPHERE; HEMISPHERIC DOMINANCE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NEUROFIBROMATOSIS; NEUROIMAGING; OCCIPITAL CORTEX; PARIETAL LOBE; REMISSION; STATISTICAL SIGNIFICANCE; THALAMUS; WHITE MATTER;

ADOLESCENT; ADULT; ANISOTROPY; BRAIN; CAUDATE NUCLEUS; CEREBRAL CORTEX; CORPUS STRIATUM; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; NEUROFIBROMATOSIS 1; THALAMUS;

EID: 34247280126     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Friedman JM, Gutmann DH, Riccardi VM. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore: The Johns Hopkins University Press; 1999
2. Viskochil D. Genetics of neurofibromatosis 1 and the NF-1 gene. J Child Neurol 2002;17:562-70; discussion 571-562, 646-51
3. Gonen O, Wang ZJ, Viswanathan AK, et al. Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1. AJNR Am J Neuroradiol 1999;20:1333-41
4. North K. Neurofibromatosis type 1. Am J Med Genet 2000;97:119-27
5. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988;45:575-78
6. Barkovich AJ. Pediatric Neuroimaging, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005
7. Hyman SL, Gill DS, Shores EA, et al. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF-1. Neurology 2003;60:1139-45
8. Menor F, Marti-Bonmati L, Arana E, et al. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. Eur J Radiol 1998;26:121-31
9. Mirowitz SA, Sartor K, Gado M. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis. AJR Am J Roentgenol 1990;154:369-73
10. Terada H, Barkovich AJ, Edwards MS, et al. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. AJNR Am J Neuroradiol 1996;17:755-60
11. Itoh T, Magnaldi S, White RM, et al. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 1994;15:1513-19
12. Moore BD, Slopis JM, Schomer D, et al. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-68
13. Aoki S, Barkovich AJ, Nishimura K, et al. Neurofibromatosis types 1 and 2: cranial MR findings. Radiology 1989;172:527-34
14. Sevick RJ, Barkovich AJ, Edwards MS, et al. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR Am J Roentgenol 1992;159:171-75
15. Griffiths PD, Blaser S, Mukonoweshuro W, et al. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?Pediatrics 1999;104:e49
16. DiPaolo DP, Zimmerman RA, Rorke LB, et al. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 1995;195:721-24
17. North K. Neurofibromatosis Type I in Childhood. London: MacKeith Press; 1997
18. Moore BD 3rd, Slopis JM, Jackson EF, et al. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 2000;54:914-20
19. Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999;42:515-25
20. Alexander DC, Barker GJ. Optimal imaging parameters for fiber-orientation estimation in diffusion MRI. Neuroimage 2005;27:357-67
21. Holz M, Heil SR, Sacco A. Temperature-dependent self-diffusion coefficients of water and six selected molecular liquids for calibration in accurate H-1 NMR PFG measurements. Phys Chem Chem Phys 2000;2:4740-42
22. Alkan A, Sigirci A, Kutlu R, et al. Neurofibromatosis type 1: diffusion weighted imaging findings of brain. Eur J Radiol 2005;56:229-34
23. Eastwood JD, Fiorella DJ, MacFall JF, et al. Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology 2001;219:354-58
24. Sheikh SF, Kubal WS, Anderson AW, et al. Longitudinal evaluation of apparent diffusion coefficient in children with neurofibromatosis type 1. J Comput Assist Tomogr 2003;27:681-86
25. Ashtari M, Kumra S, Bhaskar SL, et al. Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol Psychiatry 2005;57:448-55
26. Fukuda H, Horiguchi J, Ono C, et al. Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy. Acta Radiol 2005;46:104-09
27. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 2002;15:435-55
28. Tognini G, Ferrozzi F, Garlaschi G, et al. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1. J Comput Assist Tomogr 2005;29:298-304
29. Snook L, Paulson LA, Roy D, et al. Diffusion tensor imaging of neurodevelopment in children and young adults. Neuroimage 2005;26:1164-73